Belloxa - Oxaliplatin

Belloxa - Oxaliplatin
Product Description

Composition Oxaliplatin 50 mg &100 mg

Indication
Adjuvant treatment of stage III colon cancer (Duke stage C) after complete resection of initial tumor, treatment of metastatic colorectal cancer

Read more Show less

PTCKD OTTO Pharmaceuticals

  • ID
  • 2022
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Halal Ingredients; Price
  • Model
    Liquid Injection
  • Supplied from
    Indonesia
  • Measured In
    milligram
More specifications Fewer specifications
Sales Markets
Show more Show less

PTCKD OTTO Pharmaceuticals

  • ID
  • 2022
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile

More Products from PTCKD OTTO Pharmaceuticals (2)

  • Pemecine - Pemetrexed

    Product Pemecine - Pemetrexed

    Composition: Pemetrexed 100 mg & 500 mg

    Indication: The treatment of malignant pleural mesothelioma & non-small cell lung cancer

    Packed in : Dry vial 100 mg & 500 mg

  • Tezobell - Bortezomib

    Product Tezobell - Bortezomib

    Composition: Bortezomib 3.5 mg

    Indication: 
    The treatment of multiple myeloma patients who have received at least 1 prior therapy and have demonstrated disease progression on the last therapy. 

    Packed in : Dry vial 3.5 mg